🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› France
Clinical trial register · European Union · CTIS

Clinical Trials in France

The most recently authorised trials on the EU Clinical Trials Information System (CTIS), the single register for every trial run under the EU Clinical Trials Regulation (536/2014). CTIS holds a far larger historical archive than any one list can usefully show — this register states both numbers rather than picking one.

Download CSV
Source: EMA Clinical Trials Information System (CTIS). Showing the 2500 most recently authorised of 12445 total CTIS records — a stated recency window, not the full historical archive. Synced 20 Sep 2026, 03:17 UTC
2500
Shown in this register
most recently authorised
12,445
Total on CTIS
full historical archive
745
Phase III
within the shown window
Top member states
Spain 1023 France 890 Germany 861 Italy 742 Poland 581 Netherlands 524
Narrow the registerReset
Phase
Phase I 558 Phase I/II 214 Phase II 726 Phase III 745 Phase IV 257
Lead sponsor
AstraZeneca AB 60 Assistance Publique Hopitaux De Paris 49 Merck Sharp & Dohme LLC 48 Pfizer Inc. 45 Novo Nordisk A/S 42
Member state
Spain 1023 France 890 Germany 861 Italy 742 Poland 581 Netherlands 524 Belgium 426 Czechia 327
All 28 states
89 of 2500 shown studies
Download
Phase
Study
Lead sponsor
Area
Member states
Decision
Phase I
A Phase 1 first-in-human study to evaluate SAR447754 in healthy adult participants and in adult participants with moderate-to-severe atopic dermatitis.
2025-523826-41-00Dermatitis atopic
Sanofi-Aventis Recherche & Developpement
Immune System Diseases
Belgium, Czechia, France, Hungary, Poland, Spain, Bulgaria
16/02/2026
Phase I
A phase 1, open-label, dose-escalation and dose-expansion study evaluating the safety, feasability and efficacy of ODI-2001 vaccine, a personalized immunotherapy, in patients with metastatic or locally advanced colon cancer of pancreatic cancer
2025-523172-23-00Metastatic or locally advanced pancreatic cancer, Metastati…
Centr Georges Francois Leclerc
Digestive System Diseases
France
10/02/2026
Phase I
A Phase 1 Study of AJ1-11095 in Adults with Myelofibrosis Failed by a JAK2 Inhibitor
2025-522033-64-00Myelofibrosis
Ajax Therapeutics Inc.
Neoplasms
Italy, France, Spain
09/02/2026
Phase I
A Phase 1/1b First-in-Human Study of BMS-986506 in ccRCC
2025-522543-18-00Advanced Clear Cell Renal Cell Carcinoma
Bristol-Myers Squibb Services Unlimited Company
Neoplasms
Spain, France
09/02/2026
Phase I
A trial to test the safety and tolerability of Lu AH70212 and Lu AH69593 in healthy adults.
2025-522652-58-01Narcolepsy
H. Lundbeck A/S
Nervous System Diseases
France
09/02/2026
Phase I
A Randomised, Open-Label, Single-Centre, Study to Evaluate the Bioequivalence of Lanifibranor
2025-524385-18-00Non-alcoholic steatohepatitis
Inventiva
Digestive System Diseases
France
04/02/2026
Phase I
A Phase 1 Study of AUTX-703 in Participants with Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes
2025-521394-13-00Relapsed/refractory Acute Myeloid Leukemia or relapsed/refr…
Auron Therapeutics Inc.
Neoplasms
France
04/02/2026
Phase I
A Study of JNJ-90301900 in Combination with Concurrent Chemoradiation Therapy in LA HNSCC
2025-522914-22-00Locally Advanced Head and Neck Squamous Cell Carcinoma (LA …
Janssen Cilag International
Neoplasms
France, Spain
02/02/2026
Phase I
An Experimental Medicine multicenter Trial to evaluate the safety and immunogenicity of experimental versus authorized SARS-CoV-2 vaccine candidates as a booster dose in healthy participants previously vaccinated with authorized mRNA SARS-CoV-2 vaccines.
2025-520652-28-00healthy participants
ANRS Maladies Infectieuses Emergentes
Pathological Conditions, Signs and Symptoms
France
21/01/2026
Phase I
A study of gilteritinib in adults with advanced ALK-positive non-small cell lung cancer (NSCLC)
2025-522398-12-00Locally advanced or metastatic NSCLC
Astellas Pharma Global Development Inc.
Neoplasms
France, Spain
14/01/2026
Phase I
A Phase 1, Open-Label, Multicenter Study of INCB160058 in Participants With Myeloproliferative Neoplasms.
2024-520353-21-00Myeloproliferative Neoplasms
Incyte Corp.
Neoplasms
Norway, Germany, France, Italy
14/01/2026
Phase I
A trial to investigate the safety and pharmacokinetics of GRT6019 in healthy male participants.
2025-523587-20-00Not applicable for phase I study
Gruenenthal GmbH
Not possible to specify
France
19/12/2025
Phase I
First-in-Human trial of DS9051b in participants with advanced solid tumors
2025-521886-28-00Advanced or Metastatic Adrenocortical Carcinoma (ACC), Meta…
Daiichi Sankyo Inc.
Neoplasms
France
03/12/2025
Phase I
A study to find a suitable dose of ASP5834 in adults with solid tumors
2025-522082-29-00Locally advanced (unresectable) or metastatic solid tumor m…
Astellas Pharma Inc.
Neoplasms
Spain, France
28/11/2025
Phase I
A First In Human Phase I Trial Evaluating safety, tolErability and ResponSe of [211At]At-Girentuximab (ATO-101™) in PatiEnts with Non-Muscle-InVasive BladdER CANCEr Refractory to Standard Treatment (PERSEVERANCE EU)
2023-509729-33-00Non-Muscle-Invasive Bladder Cancer (NMIBC) refractory
Institut De Cancerologie De L Ouest
Neoplasms
France
26/11/2025
Phase I
A Phase 1b open label pilot study of CLN-978 for the treatment of moderate to severe systemic lupus erythematosus (SLE)
2024-518780-36-00Systemic Lupus Erythematosus
Cullinan Therapeutics Inc.
Musculoskeletal Diseases
Bulgaria, Romania, France, Germany, Spain, Poland
25/11/2025
Phase I
A Phase 1 Study of JNJ-89862175, an Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 3 Antibody Drug Conjugate, for Advanced Solid Tumors.
2025-521407-52-00Advanced Solid Tumors
Janssen Cilag International
Neoplasms
France
21/11/2025
Phase I
Subcutaneous Trastuzumab Deruxtecan Phase 1 Trial.
2024-516625-31-00Advanced Solid Tumor
Daiichi Sankyo Inc.
Neoplasms
Spain, France
30/10/2025
Phase I
European, multicentre, single arm (phase I) trial of autologous skeletal muscle derived cell (ASMDC) microcarrier combination for the treatment of faecal incontinence (FI) in women with obstetric anal sphincter injury.
2023-504282-23-00Faecal incontinence
University College London
Female Urogenital Diseases and Pregnancy Complications
France, Spain, Austria, Denmark
28/10/2025
Phase I
AMG 410 Alone and in Combination with other agents in Participants with KRAS Altered Advanced or Metastatic Solid Tumors
2025-521707-48-00KRAS Altered Advanced or Metastatic Solid Tumors
Amgen Inc.
Neoplasms
France, Netherlands, Germany, Denmark, Spain, Italy, Belgium
28/10/2025
Phase I
A Study Testing the Investigational Drug XmAb541 in people with Advanced Cancer
2025-521981-90-00Advanced Solid Tumors
Xencor Inc.
Neoplasms
Spain, France, Belgium, Denmark
27/10/2025
Phase I
A phase 1, Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt (EYP651) and Evaluation of Potential Drug-Drug Interactions.
2025-522915-40-00Healthy volunteers, Impaired renal function and suspected M…
ENYO Pharma
Digestive System Diseases
France
09/10/2025
Phase I
Dose Escalation Study with Bispecific Antibodies in Adult Patients with Lupus Nephritis
2024-518288-37-00Lupus Nephritis
Regeneron Pharmaceuticals Inc.
Immune System Diseases
Spain, France, Germany
07/10/2025
Phase I
Phase 1b Study of Tarlatamab in Combination with YL201 with or without Anti-PD-L1 in Subjects with Extensive Stage Small Cell Lung Cancer (DeLLphi-310)
2024-515903-21-00Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Amgen Inc.
Neoplasms
France, Germany, Spain, Greece, Hungary, Italy
30/09/2025
Phase I
FT819 in B-cell Mediated Autoimmune Diseases
2024-517397-25-00B-cell Mediated Autoimmune Diseases
Fate Therapeutics Inc.
Immune System Diseases
France, Sweden, Germany
30/09/2025
Rows per page Showing 51–75 of 89
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). EU Clinical Trials Register (CTIS), filtered. Derived from the EMA Clinical Trials Information System. Retrieved 20 September 2026. https://priyalifescience.com/clinical-trials-europe/country/france

Query this register directly
GET /api/export.php?register=trials-eu&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. Looking for Irish sites? See the Ireland, UK or USA registers. For approved medicines, see the EMA Approvals Tracker.